Respiratory infections: A current and future threat Series

Respirology

Volumn 14, Issue 5, 2009, Pages 651-655

  Waterer, Grant ^a,b   Wunderink, Richard ^c  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Burden; Cost; Respiratory infection

Indexed keywords

ANTIBIOTIC AGENT; CORTICOSTEROID; DROTECOGEN ALPHA; INTERLEUKIN 10; MONOCLONAL ANTIBODY; TUMOR NECROSIS FACTOR INHIBITOR; UNCLASSIFIED DRUG;

ARTICLE; ASTHMA; CD4+ T LYMPHOCYTE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMMUNITY ACQUIRED PNEUMONIA; DISEASE COURSE; DISEASE TRANSMISSION; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL FACTOR; HOSPITAL INFECTION; HOST PATHOGEN INTERACTION; HUMAN; IMMUNE RESPONSE; INFECTION RISK; MORBIDITY; MORTALITY; MYCOBACTERIUM TUBERCULOSIS; PATHOGENESIS; PNEUMONIA; PREVENTIVE HEALTH SERVICE; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; RISK ASSESSMENT; SEPSIS; SEVERE ACUTE RESPIRATORY SYNDROME; STREPTOCOCCUS PNEUMONIA; TUBERCULOSIS;

ANTI-BACTERIAL AGENTS; ANTIVIRAL AGENTS; COST OF ILLNESS; HEALTH CARE COSTS; HUMANS; PREVALENCE; RESPIRATORY TRACT INFECTIONS;

EID: 68149105808     PISSN: 13237799     EISSN: 14401843     Source Type: Journal    
DOI: 10.1111/j.1440-1843.2009.01554.x     Document Type: Article

References (52)

1. World Health Organization. Top ten causes of death. 2004 accessed May 1 2009 at http://www.who.int/mediacentre/factsheets/fs310/en/index.html.
2. Dixon RE. Economic costs of respiratory tract infections in the United States. Am. J. Med. 1985 78 : 45 51.
3. Fendrick AM, Monto AS, Nightengale B, Sarnes M. The economic burden of non-influenza-related viral respiratory tract infection in the United States. Arch. Intern. Med. 2003 163 : 487 94.
4. Molinari NA, Ortega-Sanchez IR, Messonnier ML, Thompson WW, Wortley PM, Weintraub E, Bridges CB. The annual impact of seasonal influenza in the US: measuring disease burden and costs. Vaccine 2007 25 : 5086 96.
5. Birnbaum HG, Morley M, Greenberg PE, Colice GL. Economic burden of respiratory infections in an employed population. Chest 2002 122 : 603 11.
6. Lo JY, Tsang TH, Leung YH, Yeung EY, Wu T, Lim WW. Respiratory infections during SARS outbreak, Hong Kong, 2003. Emerg. Infect. Dis. 2005 11 : 1738 41.
7. Panagea S, Winstanley C, Walshaw MJ, Ledson MJ, Hart CA. Environmental contamination with an epidemic strain of Pseudomonas aeruginosa in a Liverpool cystic fibrosis centre, and study of its survival on dry surfaces. J. Hosp. Infect. 2005 59 : 102 7.
8. Robinson P, Carzino R, Armstrong D, Olinsky A. Pseudomonas cross-infection from cystic fibrosis patients to non-cystic fibrosis patients: implications for inpatient care of respiratory patients. J. Clin. Microbiol. 2003 41 : 5741.
9. Bloemendaal AL, Fluit AC, Jansen WM, Vriens MR, Ferry T, Argaud L, Amorim JM et al. Acquisition and cross-transmission of Staphylococcus aureus in European intensive care units. Infect. Control Hosp. Epidemiol. 2009 30 : 117 24.
10. Boccia S, Laurenti P, Borella P, Moscato U, Capalbo G, Cambieri A, Amore R et al. Prospective 3-year surveillance for nosocomial and environmental Legionella pneumophila: implications for infection control. Infect. Control Hosp. Epidemiol. 2006 27 : 459 65.
11. Marrie TJ, MacDonald S, Clarke K, Haldane D. Nosocomial legionnaires' disease: lessons from a four-year prospective study. Am. J. Infect. Control 1991 19 : 79 85.
12. Construction-related nosocomial infections in patients in health care facilities. Decreasing the risk of Aspergillus, Legionella and other infections. Can. Commun. Dis. Rep. 2001 27 (Suppl 2 i x.
13. Sherertz RJ, Belani A, Kramer BS, Elfenbein GJ, Weiner RS, Sullivan ML, Thomas RG et al. Impact of air filtration on nosocomial Aspergillus infections. Unique risk of bone marrow transplant recipients. Am. J. Med. 1987 83 : 709 18.
14. Passamonte PM, Dix JD. Nosocomial pulmonary mucormycosis with fatal massive hemoptysis. Am. J. Med. Sci. 1985 289 : 65 7.
15. Rosenthal VD, Maki DG, Graves N. The International Nosocomial Infection Control Consortium (INICC): goals and objectives, description of surveillance methods, and operational activities. Am. J. Infect. Control 2008 36 : e1 12.
16. Aw D, Silva AB, Palmer DB. Immunosenescence: emerging challenges for an ageing population. Immunology 2007 120 : 435 46.
17. Licastro F, Candore G, Lio D, Porcellini E, Colonna-Romano G, Franceschi C, Caruso C. Innate immunity and inflammation in ageing: a key for understanding age-related diseases. Immun. Ageing 2005 2 : 8.
18. De Martinis M, Franceschi C, Monti D, Ginaldi L. Inflamm-ageing and lifelong antigenic load as major determinants of ageing rate and longevity. FEBS Lett. 2005 579 : 2035 9.
19. Garcia-Vidal C, Fernandez-Sabe N, Carratala J, Diaz V, Verdaguer R, Dorca J, Manresa F et al. Early mortality in patients with community-acquired pneumonia: causes and risk factors. Eur. Respir. J. 2008 32 : 733 9.
20. Caram LB, Chen J, Taggart EW, Hillyard DR, She R, Polage CR, Twersky J et al. Respiratory syncytial virus outbreak in a long-term care facility detected using reverse transcriptase polymerase chain reaction: an argument for real-time detection methods. J. Am. Geriatr. Soc. 2009 57 : 482 5.
21. Nakashima K, Tanaka T, Kramer MH, Takahashi H, Ohyama T, Kishimoto T, Toshima H et al. Outbreak of Chlamydia pneumoniae infection in a Japanese nursing home, 1999-2000. Infect. Control Hosp. Epidemiol. 2006 27 : 1171 7.
22. Hicks LA, Shepard CW, Britz PH, Erdman DD, Fischer M, Flannery BL, Peck AJ et al. Two outbreaks of severe respiratory disease in nursing homes associated with rhinovirus. J. Am. Geriatr. Soc. 2006 54 : 284 9.
23. Tan CG, Ostrawski S, Bresnitz EA. A preventable outbreak of pneumococcal pneumonia among unvaccinated nursing home residents in New Jersey during 2001. Infect. Control Hosp. Epidemiol. 2003 24 : 848 52.
24. Nuorti JP, Butler JC, Crutcher JM, Guevara R, Welch D, Holder P, Elliott JA. An outbreak of multidrug-resistant pneumococcal pneumonia and bacteremia among unvaccinated nursing home residents. N. Engl. J. Med. 1998 338 : 1861 8.
25. Libow LS, Neufeld RR, Olson E, Breuer B, Starer P. Sequential outbreak of influenza A and B in a nursing home: efficacy of vaccine and amantadine. J. Am. Geriatr. Soc. 1996 44 : 1153 7.
26. Fine MJ, Smith MA, Carson CA, Mutha SS, Sankey SS, Weissfeld LA, Kapoor WN. Prognosis and outcomes of patients with community-acquired pneumonia. A meta-analysis. Jama 1996 275 : 134 41.
27. McElhaney JE, Xie D, Hager WD, Barry MB, Wang Y, Kleppinger A, Ewen C et al. T cell responses are better correlates of vaccine protection in the elderly. J. Immunol. 2006 176 : 6333 9.
28. Muszkat M, Friedman G, Dannenberg HD, Greenbaum E, Lipo M, Heymann Y, Zakay-Rones Z et al. Response to influenza vaccination in community and in nursing home residing elderly: relation to clinical factors. Exp. Gerontol. 2003 38 : 1199 203.
29. Cavdar C, Sayan M, Sifil A, Artuk C, Yilmaz N, Bahar H, Camsari T. The comparison of antibody response to influenza vaccination in continuous ambulatory peritoneal dialysis, hemodialysis and renal transplantation patients. Scand. J. Urol. Nephrol. 2003 37 : 71 6.
30. Feldmann M, Maini SR. Role of cytokines in rheumatoid arthritis: an education in pathophysiology and therapeutics. Immunol. Rev. 2008 223 : 7 19.
31. Singh S, Amin AV, Loke YK. Long-term use of inhaled corticosteroids and the risk of pneumonia in chronic obstructive pulmonary disease: a meta-analysis. Arch. Intern. Med. 2009 169 : 219 29.
32. Austrian R, Gold J. Pneumococcal bacteremia with special reference to bacteremic pneumococcal pneumonia. Ann. Intern. Med. 1964 60 : 759 76.
33. Waterer GW, Somes GW, Wunderink RG. Monotherapy may be suboptimal for severe bacteremic pneumococcal pneumonia. Arch. Intern. Med. 2001 161 : 1837 42.
34. Baddour LM, Yu VL, Klugman KP, Feldman C, Ortqvist A, Rello J, Morris AJ et al. Combination antibiotic therapy lowers mortality among severely ill patients with pneumococcal bacteremia. Am. J. Respir. Crit. Care Med. 2004 170 : 440 4.
35. Simpson JC, Macfarlane JT, Watson J, Woodhead MA. A national confidential enquiry into community acquired pneumonia deaths in young adults in England and Wales. British Thoracic Society Research Committee and Public Health Laboratory Service. Thorax 2000 55 : 1040 5.
36. Kelly C, Krueger P, Lohfeld L, Loeb M, Edward HG. 'I really should've gone to the doctor': older adults and family caregivers describe their experiences with community-acquired pneumonia. BMC Fam. Pract. 2006 7 : 30.
37. Laterre PF, Garber G, Levy H, Wunderink R, Kinasewitz GT, Sollet JP, Maki DG, et al. Severe community-acquired pneumonia as a cause of severe sepsis: data from the PROWESS study. Crit. Care Med. 2005 33 : 952 61.
38. Feldman C, Anderson R. New insights into pneumococcal disease. Respirology 2009 14 : 167 79.
39. Luna CM, Aruj P, Niederman MS, Garzon J, Violi D, Prignoni A, Rios F et al. Appropriateness and delay to initiate therapy in ventilator-associated pneumonia. Eur. Respir. J. 2006 27 : 158 64.
40. Iregui M, Ward S, Sherman G, Fraser VJ, Kollef MH. Clinical importance of delays in the initiation of appropriate antibiotic treatment for ventilator-associated pneumonia. Chest 2002 122 : 262 8.
41. Masterton RG, Galloway A, French G, Street M, Armstrong J, Brown E, Cleverley J et al. Guidelines for the management of hospital-acquired pneumonia in the UK: report of the working party on hospital-acquired pneumonia of the British Society for Antimicrobial Chemotherapy. J. Antimicrob. Chemother. 2008 62 : 5 34.
42. Rotstein C, Evans G, Born A, Grossman R, Light RB, Magder S, McTaggart B et al. Clinical practice guidelines for hospital-acquired pneumonia and ventilator-associated pneumonia in adults. Can. J. Infect. Dis. Med. Microbiol. 2008 19 : 19 53.
43. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am. J. Respir. Crit. Care Med. 2005 171 : 388 416.
44. Suzuki T, Tahara H, Narula S, Moore KW, Robbins PD, Lotze MT. Viral interleukin 10 (IL-10), the human herpes virus 4 cellular IL-10 homologue, induces local anergy to allogeneic and syngeneic tumors. J. Exp. Med. 1995 182 : 477 86.
45. Hsueh PR, Tseng SP, Teng LJ, Ho SW. Pan-drug-resistant Pseudomonas aeruginosa causing nosocomial infection at a university hospital in Taiwan. Clin. Microbiol. Infect. 2005 11 : 670 3.
46. Yew WW, Leung CC. Management of multidrug-resistant tuberculosis: update 2007. Respirology 2008 13 : 21 46.
47. Kallen AJ, Brunkard J, Moore Z, Budge P, Arnold KE, Fosheim G, Finelli L et al. Staphylococcus aureus community-acquired pneumonia during the 2006 to 2007 influenza season. Ann. Emerg. Med. 2009 53 : 358 65.
48. Lackenby A, Hungnes O, Dudman SG, Meijer A, Paget WJ, Hay AJ, Zambon MC. Emergence of resistance to oseltamivir among influenza A(H1N1) viruses in Europe. Euro. Surveill. 2008 13.
49. Drosten C, Gunther S, Preiser W, van der Werf S, Brodt HR, Becker S, Rabenau H et al. Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N. Engl. J. Med. 2003 348 : 1967 76.
50. Waterer GW, Robertson H. Bioterrorism for the respiratory physician. Respirology 2009 14 : 5 11.
51. Thomson RM, Yew WW. When and how to treat pulmonary non-tuberculous mycobacterial diseases. Respirology 2009 14 : 12 26.
52. Mera R, Miller LA, Fritsche TR, Jones RN. Serotype replacement and multiple resistance in Streptococcus pneumoniae after the introduction of the conjugate pneumococcal vaccine. Microb. Drug Resist. 2008 14 : 101 7.